Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis.
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.
Azcona
C
C
Department of Paediatrics, University Clinic of Navarra, Faculty of Medicine, Pamplona, Spain.
Alzina
V
V
Barona
P
P
Sierrasesúmaga
L
L
Villa-Elízaga
I
I
D016026:Bone Marrow Transplantation; D017809:Fatal Outcome; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D016511:Severe Combined Immunodeficiency / Q000188:drug therapy* / Q000628:therapy
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor